Yarrow Bioscience
YARW32.9908.34% ( +2.540 )
Yarrow Bioscience (YARW)
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases....
- Open
- 30.090
- High
- 34.355
- Low
- 29.800
- Prev. Close
- 30.450
- Volume
- 22.10K
- Turnover
- 715.63K
- Avg Price
- 32.382
- Bid/Ask Ratio
- --
- Amplitude
- 14.96%
- 52wk High
- 34.355
- Volume Ratio
- 0.00
- Turnover Ratio
- 3.61%
News
- businessinsider · Jul 25 at 12:59 AM
VYNE Therapeutics trading halted, news pending
- benzinga_article · Jul 24 at 03:35 AM
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- PUBT · Jul 23 at 03:50 PM
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24
- StockTitan · Jul 23 at 07:26 AM
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience | VYNE Stock News
- rttnews · Jul 21 at 07:35 AM
VYNE Therapeutics Sets 1-for-50 Reverse Stock Split Ahead Of Yarrow Merger
- PUBT · Jul 21 at 07:05 AM
Vyne Therapeutics executes 1-for-50 reverse stock split
